Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial
Language English Country Japan Media print-electronic
Document type Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
29777297
DOI
10.1007/s00380-018-1184-7
PII: 10.1007/s00380-018-1184-7
Knihovny.cz E-resources
- Keywords
- Bioabsorbable scaffold, Coronary blood flow, Optical coherence tomography, STEMI,
- MeSH
- Time Factors MeSH
- Everolimus pharmacology MeSH
- ST Elevation Myocardial Infarction diagnosis physiopathology surgery MeSH
- Coronary Angiography MeSH
- Percutaneous Coronary Intervention MeSH
- Coronary Vessels diagnostic imaging surgery MeSH
- Coronary Circulation physiology MeSH
- Humans MeSH
- Tomography, Optical Coherence methods MeSH
- Prospective Studies MeSH
- Prosthesis Design MeSH
- Regional Blood Flow physiology MeSH
- Drug-Eluting Stents MeSH
- Tissue Scaffolds * MeSH
- Absorbable Implants * MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Everolimus MeSH
This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable scaffold implantation. Only few data about OCT use in STEMI are available and coronary flow before and after OCT is not well studied yet. 54 patients with OCT performed at the end of procedure from the Prague 19 trial were selected and coronary flow was evaluated as TIMI frame count (TFC) before and just after OCT. Significant increase in TIMI frame count after OCT [from 9.5 (6.75-12.25) to 11.5 (8-15.25) frames; p = 0.001] and high verapamil administration (18%) was reported. OCT at the end of primary percutaneous coronary intervention with bioresorbable scaffold is a feasible procedure. However, it seems to be associated with flow deterioration.
See more in PubMed
Circulation. 2016 Sep 27;134(13):906-17 PubMed
Science. 1991 Nov 22;254(5035):1178-81 PubMed
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):96-107 PubMed
Am J Cardiol. 2008 Mar 1;101(5):562-7 PubMed
Lancet. 2016 Nov 26;388(10060):2618-2628 PubMed
EuroIntervention. 2009 May;5(1):90-5 PubMed
EuroIntervention. 2010 Nov;6(5):575-81 PubMed
Circulation. 1996 Mar 1;93(5):879-88 PubMed
Eur Heart J. 2010 Feb;31(4):401-15 PubMed
Eur Heart J. 2014 Mar;35(12):787-94 PubMed
Lancet. 2008 Mar 15;371(9616):899-907 PubMed